Company Filing History:
2 out of 2,079 
1 out of 1,458 
Years Active: 2022-2025
Title: Gary Eichenbaum: Innovator in Vascular Integrity and Toxic Mitigation
Introduction
Gary Eichenbaum is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the fields of medical technology and toxicology, holding a total of 2 patents. His work focuses on methods that enhance patient safety and treatment efficacy.
Latest Patents
Eichenbaum's latest patents include innovative methods aimed at protecting vascular integrity during targeted radiation therapy. These methods utilize an effective amount of a thrombopoietin (TPO) mimetic, such as TPOm, to safeguard vascular integrity following radiation exposure. Additionally, he has developed methods and kits designed to mitigate the toxic effects of vesicants and caustic gases. In this case, an effective amount of a thrombopoietin (TPO) mimetic, such as RWJ-800088 or romiplostim, is employed to alleviate the toxic effects experienced by affected subjects.
Career Highlights
Throughout his career, Gary Eichenbaum has worked with prominent organizations, including Janssen Pharmaceutica and Rutgers, the State University of New Jersey. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Eichenbaum has collaborated with esteemed colleagues, including Edward John Yurkow and Alfred Tonelli. These partnerships have contributed to the advancement of his innovative work and the successful development of his patents.
Conclusion
Gary Eichenbaum's contributions to medical technology and toxicology demonstrate his commitment to improving patient outcomes through innovation. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective solutions.